CTIM-35. MULTI-OMIC AND SINGLE CELL ASSESSMENT OF SERIAL BIOPSIES REVEALS RESPONSES TO CAN-3110 ONCOLYTIC IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA THAT ARE NOT EVIDENT BY ROUTINE CLINICAL ANALYSES
Alexander Ling(Centre for Quantum Technologies), E Antonio Chiocca(Brigham and Women's Hospital), Giacomo Oliveira(Dana-Farber Cancer Institute), Georges Ayoub(Harvard University), Keith L. Ligon(Brigham and Women's Hospital), Jennifer Gantchev(Center for Pain and the Brain), Kenny Yu(Memorial Sloan Kettering Cancer Center), P. B. Edwin Prabhakar(Dana-Farber Cancer Institute), Charles A. Whittaker(Imperial College London), Dina ElHarouni(Harvard University), Nathalie Y.R. Agar(Texas Endosurgery Institute), Alicia D. D’Souza(Massachusetts Institute of Technology), Gerard Baquer(Center for Pain and the Brain), David A. Reardon(Dana-Farber Cancer Institute), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Michael S. Regan(Brigham and Women's Hospital), Sreyashi Basu(The University of Texas MD Anderson Cancer Center), Zaki Abou-Mrad(Memorial Sloan Kettering Cancer Center), Charles Couturier(Broad Institute), Forest M. White(Center for Cancer Research), G B M TeamLab(Breakthrough), Ryuhjin Ahn(Allen Institute)
Cited by 0
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k